Interventional Radiology Billing 2026: Codes, Supervision Levels and Denial Prevention

By Rcmaxis Revenue Cycle Team  ·  September 2026  ·  15 min read

Interventional radiology billing sits at the intersection of three different CPT code families: catheter-based procedures, imaging guidance, and evaluation and management. Each has its own rules. The technical and professional component split is straightforward in concept and consistently wrong in practice. And the supervision requirements that govern who can bill the professional component are tighter in IR than in almost any other specialty, which means one documentation gap can void an entire procedure's professional claim.

This guide covers what actually matters for interventional radiology billing in 2026: catheter hierarchy rules, imaging guidance coding, supervision levels, the office-based lab vs hospital outpatient distinction, and the denial patterns that hit IR groups hardest.

Understanding the TC and Professional Component Split in Interventional Radiology Billing

Whether you're in a hospital outpatient department, an office-based lab, or an ambulatory surgery center determines how your IR procedures are billed. In a hospital outpatient setting, the facility bills the technical component (equipment, staff, supplies) through the APC system. The radiologist or IR physician bills only the professional component, appending modifier 26 to applicable codes. You'll never bill a global code from the hospital outpatient setting.

In an office-based lab or ASC where the practice owns the equipment, the picture changes. The group can bill the global code without modifiers if it employs the staff and owns or leases the imaging equipment. If the practice owns the equipment but sends interpretation to an outside group, it bills TC only. The outside group billing interpretation appends modifier 26. Getting this wrong in either direction creates duplicate billing errors or missed revenue.

Catheter Placement Hierarchy and CPT Code Selection

Catheter-based procedures follow a strict hierarchy. You code to the highest order catheter placement achieved during the procedure, then add any selective catheter placements as add-on codes. This is the part that gets coded wrong most often, because coders who aren't fluent in vascular anatomy default to non-selective codes even when selective placement was documented and billed by the physician.

The operative report must document the specific named vessel entered at each level of selectivity. "Catheter was advanced selectively" without naming the vessel is not sufficient for selective catheter code billing. If auditors see selective catheter codes without vessel-level documentation in the report, they'll downcode every claim to 36200, which is exactly what RAC auditors have been doing since 2023.

Imaging Guidance Codes: What's Included and What's Separately Billable

This is the single biggest source of both overbilling (billing guidance separately when it's bundled) and underbilling (not capturing payable guidance when it's legitimately separate). Fluoroscopy and ultrasound guidance have different rules, and those rules change depending on the parent procedure code.

Supervision Level Requirements in Interventional Radiology

Supervision level determines who must be present and where for the professional component claim to be valid. IR procedures fall primarily into direct supervision (level 2) and personal supervision (level 3).

Under direct supervision, the physician must be immediately available to furnish assistance and direction throughout the procedure. Present in the building, not necessarily in the room, but able to enter the procedure suite at a moment's notice. This covers most IR procedures in a hospital outpatient department where residents or mid-levels may be performing portions of the procedure.

Personal supervision (level 3) is required for a smaller subset of procedures, including some nuclear medicine imaging services that may accompany IR procedures. When personal supervision is required, the physician must be present in the room for the entire time the service is being performed. A physician who steps out of the room during a personal-supervision procedure cannot bill the professional component for that service.

Office-Based Lab Billing: Global Code Opportunities and Risks

The shift toward office-based IR labs has created real billing complexity. When done right, an OBL practice can bill global codes and capture both TC and professional revenue on a single claim. The revenue difference is significant. A diagnostic angiography at hospital outpatient pays the radiologist roughly $350 to $500 for the professional component. The same procedure in an OBL setting, billed globally, can generate $1,800 to $2,400 per case when the practice owns the equipment.

The requirements to bill globally from an OBL are strict. The practice must own or have a long-term lease on the imaging equipment. A physician who holds the required supervision level must be present or immediately available depending on the procedure. The practice must maintain its own accreditation for the procedures it performs. And the space cannot be classified as a provider-based department, which would push billing back into the hospital outpatient framework.

Common Denial Patterns in Interventional Radiology Billing

The denial patterns in IR billing are predictable. The same six or seven reasons account for roughly 80 percent of write-offs in most IR practices. Here's what to look for and how to fix each one.

Interventional Radiology Prior Authorization Requirements

Prior authorization requirements for IR procedures vary substantially by payer and by procedure type. Traditional Medicare doesn't require prior auth for most IR procedures, but Medicare Advantage plans frequently do, and commercial payers have tightened their auth requirements over the past two years. The most auth-intensive IR services are uterine fibroid embolization (UFE), varicose vein treatments, vertebroplasty, kyphoplasty, and chemoembolization for liver cancer.

For UFE specifically, Aetna, UnitedHealthcare, and Blue Cross plans now require documentation of failed medical therapy, a uterine fibroid mapping study (typically ultrasound or MRI), and gynecology consultation before they'll approve the procedure. Practices that submit auth requests without these three elements are consistently denied on first review, adding 10 to 18 days to the auth timeline and sometimes pushing cases to the next month.

OIG Audit Risk and RAC Targets in Interventional Radiology

The OIG Work Plan has flagged interventional radiology billing for review in three consecutive annual plans, and RAC contractors have been active in this space since 2022. The auditors are focused on four specific risk areas.

First, catheter placement upcoding. RAC contractors have recovered over $8 million from IR groups in the last two audit cycles by identifying non-selective catheter placement coded as first-order selective without supporting documentation. The lookback period is 36 months, so a billing pattern from 2024 is still within scope today.

Second, imaging guidance unbundling. OIG reports from 2024 and 2025 identified that roughly 23 percent of sampled IR claims included imaging guidance codes that were bundled under NCCI edits and should not have been separately billed. Each of those claims represents a potential false claim liability under the False Claims Act, not just a simple billing error.

Third, supervision requirement failures. CMS medical review contractors have been denying professional component claims for IR procedures where the documentation doesn't confirm the required supervision level was met. In academic settings specifically, auditors look for cases where a resident performed the procedure and the attending's presence or oversight isn't clearly documented.

Fourth, UFE and varicose vein medical necessity. Both procedures have faced sustained medical review activity. Payers and auditors look for documentation of failed conservative treatment, appropriate patient selection criteria, and procedure notes that justify the intervention based on the patient's specific clinical findings. Generic templates without patient-specific detail are routinely denied.